HIV

Walgreens today announced the launch of Well Beyond HIVâ„¢, a national campaign highlighting people aging well beyond their HIV diagnosis. The centerpiece of the campaign is a traveling art exhibit, curated in collaboration with The Graying of AIDS, an independent documentary project and educational campaign. The exhibit provides a glimpse into the lives of older adults living with HIV and will make its first stop in Miami, Fla., this Saturday, Jan. 17.

Data published in The Lancet Infectious Diseases on Jan. 8 shows that some contraceptives for women may increase the risk of contracting HIV. This information comes from researchers from the University of California Berkeley, who analyzed 12 studies.

Hepatitis B vaccination reduces incidence of primary liver cancer by 84% later in life, study finds.

Research may lead to targeted therapeutic approach.

Between 50% to 70% of patients with HCV show no symptoms and may not know they have the disease.

Study finds disease leads to worse low and high frequency hearing.

Jim Demarest discusses innovations focused on advancing novel treatments that require less frequent dosing and attempt to achieve HIV cure.

This audio series discusses the role of health care providers in supporting adherence among adolescents living with HIV.

A clinical pharmacy specialist talks about care and medication treatment for patients living with HIV.

Even intermittent heroin abuse can worsen human immunodeficiency virus infections.

Raulo Frear, PharmD, general manager of OmedaRx, discusses the high initial cost of hepatitis C drugs like Sovaldi compared with the long term cost of treating the disease.

Study suggests drug has negative impact on immune system.

Product contains 3 new drugs that work to inhibit the growth of HCV.

Study finds hepatitis C co-infection not related to decreased mental function.

A rapid syphilis screening test will now be available in a greater number of health care settings.

Long-term infections with other pathogens have been suspected as the cause of mental impairment in patients with HIV. However, new research suggests that this might not be the case.

To curb an estimated 6% to 11% increase in Medicare Part D spending, 3 states have already placed limitations on which patients with chronic hepatitis C are candidates for treatment with novel antiviral agents.

Pharmacists can substantially lower risk for cardiovascular disease.

Patients with bipolar disorder and other mental illnesses are more likely to be tested for human immunodeficiency virus.

The role of pharmacists in HIV care across ambulatory care settings is expanding.

According to a new study, a CCR5-blocking drug used to treat HIV may also be able to slow prostate cancer metastasis.

Tablets treat HIV-1 infection in combination with other antiretroviral agents for pediatric patients.

Study suggests that HIV adaptations are evolving it into a weaker virus.

The FDA granted a tentative approval for 2 dosages of abacavir/lamivudine tablets for oral suspension to treat HIV-1 infection in pediatric patients, according to a Mylan, Inc, press release.

Mylan, Inc, announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead Sciences, Inc, under which Mylan has licensed the non-exclusive rights to manufacture and distribute Tenofovir Alafenamide as both a single agent product and in combination with other drugs.

Study finds that HIV drug regimens that exclude efavirenz are as effective as first-line antiretroviral treatment.

Beginning therapy within 12 months of HIV detection associated with lower AIDS risk.

Of the 1.2 million Americans with human immunodeficiency virus in 2011, 70% did not have their condition under control.

Study finds treatment that prevents transmission of virus from mother to child leads to reduced heart performance.

Three-drug regimen will lead to new treatment protocols for transplant patients, study finds.